The first dose level, evaluating 3 patients of the VIO-01-101 trial has been cleared as per the recommendations of the Clinical Review Committee. No clinically significant adverse events or
Retinoids are vitamin A derivatives responsible for regulating several physiological activities with profound importance in dermatology and skincare. They are the most widely utilized active ingredient in topical skin rejuvenation therapies.